The CDC warns against a dangerous increase in infections with antibiotic resistant bacteria

Human infections from drug-resistant bacteria are standing in the United States, Centers for Disease Control and Prevention warned.

CDC laboratory tests have shown that the occurrences of a bacteria called enterobacteral resistant to carbapenem NDM (NDM-CRE) have increased considerably.

The NDM-CRE belongs to a wider category of bacteria called Enterobacteral (CRE) resistant to Carbapenem, which have shown that some of the most powerful antibiotics available.

Common pain relievers can fuel deadly superpailles that resist antibiotics, warns the study

“NDM” refers to an enzyme called New Delhi Metallo-Beta-Lactamase, which resists almost all antibiotics, according to the report.

In 2020, NDM-CRE led around 12,700 infections and 1,100 deaths in the United States, said the source above. The current point could send these figures to increase even more.

Human infections from drug-resistant bacteria are standing in the United States, Centers for Disease Control and Prevention warned. (istock)

NDM -CRE infections – which may include urinary tract infections, pneumonia, infections in blood circulation and wound infections – increased by more than 460% between 2019 and 2023, warned the CDC.

As these infections are resistant to most antibiotics, they are very difficult to treat and can sometimes be fatal. NDM-CRE can also spread quickly in communities.

It is also easily diagnosed or neglected, noted the CDC because it has not been common in the United States and may not be on the radar of health care providers.

Click here to obtain the Fox News app

“This strong increase in NDM-CRE means that we are faced with an increasing threat that limits our ability to deal with some of the most serious bacterial infections,” said Danielle Rankin, epidemiologist of the quality of the quality of CDC health care in the CDC press release.

“The selection of good treatment has never been so complicated, it is therefore of vital importance that health care providers have access to tests to help them select the appropriate targeted therapies.”

The CDC laboratory tests have shown that the occurrences of bacteria called enterobacteral resistant to carbapenem NDM (NDM-CRE) have increased considerably. (istock)

Dr. Marc Siegel, Fox News principal medical analyst, described this as a “very worrying trend” with a “high risk of illness or serious death”.

“This is partly due to an overuse of antibiotics and a part of a global trend that generates more and more resistance,” he told Fox News Digital.

NSAIDs vs. acetaminophen: what you need to know before your next headache

The treatment of carbapenem resistant infections involves new antibiotics such as ceftazidime-avibactam, meropenème-vaborbactam, placomicinity and eravacycline, according to the doctor.

“At the same time, we don’t have enough antibiotics to treat it because it is not profitable enough to do them,” he added.

The treatment of carbapenem resistant infections involves new antibiotics such as ceftazidime-avibactam, meropenème-vaborbactam, placomicinity and eravacycline, according to Siegel. (istock)

Infectious sickness expert David Perlin, Ph.D., scientific director and executive vice-president of Hackensack Meridian Center for Discovery and Innovation in New Jersey, was not involved in the CDC study, but shared his reactions with Fox News Digital.

“This is one of the many concerns of resistance to drugs at the moment for Americans-especially since we see that surveillance does not follow the evolution of pathogens,” he said. “We can certainly do better, once we make the stakes here.”

Click here to register for our Health Newsletter

NDM-CRE infections are serious and can be fatal, confirmed Perlin.

“They constantly adapt to their environment and can acquire a range of drug resistance mechanisms that make them difficult to treat,” he said.

“Health care providers can, and must better provide tests closer to the care point, in particular in emergency services, so that these infections can be identified quickly for effective treatment and infections control,” said an expert. (istock)

“The fact that some of these strains carry special carba -plated genes – which allows the body to resist treatment with the most common antibiotic class – makes them particularly dangerous for patients with compromise immune systems.”

Perlin recommends that patients be “persistent” in interaction with doctors on any throbbing infection.

For more health items, visit www.foxnews.com/health

“Health care providers can, and must better provide tests closer to the care point, especially in emergency services, so these infections can be identified quickly for effective treatment and infection control,” he added, warning that these infections can easily spread between hospitals, nursing homes and the community.

Siegel added: “The key is to disinfect environments and early diagnosis, which is particularly important in immunocompromised patients where it can spread quickly.”